Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial.

At each assessment, the Fisher’s exact analysis of those having categorical change was highly significant ( P < 0.002), with more oral treprostinil participants having an improved risk profile and fewer having a deteriorated risk profile ( Figure 4C ).

also in 132,142 other papers